Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,658
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England
Philip Cornforda Department of Urology, Royal Liverpool University Hospitals, Liverpool, UKCorrespondence[email protected]
https://orcid.org/0000-0002-7146-9258
Caolan Halpinb Department of Market Access and Health Economics Outcomes Research, Ipsen, Slough, UK
, Jelena Sassmannc Medical Department, Ipsen, Slough, UK
, Ian Frankcomb Department of Market Access and Health Economics Outcomes Research, Ipsen, Slough, UK
& Saran Braybrookd Brunston Surgery, Coleford, UK
Pages 208-218
|
Received 25 Nov 2022, Accepted 20 Jan 2023, Published online: 07 Feb 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.